Raising Growth Investment Funds Through a Private Placement of the Seventh Series of Stock Acquisition Rights
First written in FY2025-H1. 1 of 2 entries say "Restated". Latest entry: 2026-06-26.
The whole theme swung hardest in 2020: 1 of 10 companies on the "Worse" side.
3 other companies' latest entry also says "Restated".
- 2026-06-26RestatedOccurring Fact
「None of the Series 7 Stock Acquisition Rights issued by the Company on 7 July 2025 had been exercised as of today, and 57,000 remain outstanding. The funds to be raised through the exercise of these rights are scheduled to be used for the purposes below, separately from this third-party allotment. There is no change from the uses of funds specified at the time of issuance.」
It has been reconfirmed that none of the Series 7 Stock Acquisition Rights has been exercised and that the original uses of funds, namely the acquisition and development of investment properties and the launch costs of the asset management business, remain unchanged. - FY2025-H1First statedAnnual report
「At a meeting of the Board of Directors held on 20 June 2025, the Company resolved to issue the seventh series of stock acquisition rights through a private placement, which was completed on 7 July 2025. / Number of stock acquisition rights: 57,000 / Shares underlying the rights: 5,700,000 common shares / Exercise price: ¥100 / Exercise period: 8 July 2025 to 7 July 2028」
The seventh series of stock acquisition rights was privately placed with Pentagram2号ファンド, ZUITING XIA and 呉 文偉, creating a financing instrument representing 5,700,000 potential shares. The stated use of proceeds is growth investment, including property acquisitions and business launches.